Showing results (1541-1550 of 1,736) with videos related to

Sort By:
Pageof 174
Plos One|July 28, 2025
Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort studyJulie My Van Nguyen, Danielle Vicus, Liat Hogen, et al.
Parkinsonism & Related Disorders|July 6, 2023
Development and validation of the Vietnamese smell identification testTai Ngoc Tran, Thuong Huyen Thi Dang, Truc Thanh Thai, et al.
Scientific Reports|August 13, 2021
Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutationsHoai-Nghia Nguyen, Ngoc-Phuong Thi Cao, Thien-Chi Van Nguyen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2018
Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric CohortKara Wools-Kaloustian, Irene Marete, Samuel Ayaya, et al.
BMC Cancer|May 3, 2020
Evaluation of the expression levels of BRAFV600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assayTien Viet Tran, Kien Xuan Dang, Quynh Huong Pham, et al.
Journal of Medical Microbiology|January 14, 2016
Population structure of colonizing and invasive Staphylococcus aureus strains in northern VietnamBich Ngoc Thi Vu, Alexander J Jafari, Matthew Aardema, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2002
Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotypeRichard Rozmahel, Howard T J Mount, Fusheng Chen, et al.
AIDS Research and Human Retroviruses|November 1, 2016
Short Communication: Impact of Viral Load Use on Treatment Switch in Perinatally HIV-Infected Children in AsiaThahira Jamal Mohamed, Sirinya Teeraananchai, Stephen Kerr, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Head-to-head comparison of diagnostic accuracy of TB screening tests: Chest-X-ray, Xpert TB host response, and C-reactive proteinRebecca Crowder, Balamugesh Thangakunam, Alfred Andama, et al.
Oncotargets and Therapy|March 2, 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinomaAhmed O Kaseb, Jeffrey S Morris, Michiko Iwasaki, et al.
Pageof 174